Back
Panbela Therapeutics 10K Form
Sell
25
PBLA
Panbela Therapeutics
Last Price:
0.43
Seasonality Move:
-3.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PBLA News And Ratings
See the #1 stock for the next 7 days that we like better than PBLA
PBLA Financial Statistics
Sales & Book Value
| Annual Sales: | $973.81K |
|---|---|
| Cash Flow: | $-3.08M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-9.81 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -616.28680 |
|---|---|
| Net Income (TTM): | $-25.25M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Panbela Therapeutics Earnings Forecast
Key Panbela Therapeutics Financial Ratios
- The Selling, General & Administrative Expenses for PBLA have been equal to 33.88% of Gross Profit Margin.
- The Interest Expense is -1.25% of Operating Income.
- Per Share Earnings over the last 13 years have been positive in 7 years.
Panbela Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PBLA |
| Website: | panbela.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PBLA Technical Analysis vs Fundamental Analysis
Sell
25
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy or a Sell?
-
Panbela Therapeutics stock is rated a Sell
The current Panbela Therapeutics [PBLA] share price is $0.43. The Score for PBLA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.